$Petros Pharmaceuticals (PTPI.US)$ Petros Pharmaceuticals Featured in "New Era of Healthcare, AI, Data and Consumer Empowerment" Thursday, 19th December at 9:15 am Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the c...
Here are your levels to watch after the spike yesterday. .3541 has held as support so far PM. Having backtested .3982 could see another push lower. If that .3541 levels doesn't hold watch out for a deeper retrace. $Petros Pharmaceuticals (PTPI.US)$
$Petros Pharmaceuticals (PTPI.US)$ Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually Tuesday, 17th December at 9:00 am Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a compan...
1
3
Report
tian liang
:
This company really knows how to brag.
Petros Pharmaceuticals Stock Forum
$Petros Pharmaceuticals (PTPI.US)$
$Quantum-Si (QSI.US)$
$Immuneering (IMRX.US)$
$Telomir Pharmaceuticals (TELO.US)$
Weigh it yourself
Petros Pharmaceuticals Unveils AI-Powered Platform for Revolutionary OTC Drug Transitions
Petros Pharmaceuticals Featured in "New Era of Healthcare, AI, Data and Consumer Empowerment"
Thursday, 19th December at 9:15 am
Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access
NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the c...
$Petros Pharmaceuticals (PTPI.US)$
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually
Tuesday, 17th December at 9:00 am
Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) ("Petros" or the "Company"), a compan...
👀
No comment yet